ANI Pharmaceuticals, Inc. today announced that it has acquired the approved abbreviated new drug application ("ANDA") for Flecainide Acetate tablets USP 50mg, 100mg and 150mg, previously marketed by Teva Pharmaceuticals.
from The Medical News http://ift.tt/1G1GAOt
from The Medical News http://ift.tt/1G1GAOt
No comments:
Post a Comment